Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	N-succinyltransferase activity	ALAS1 ALAS2	7.99e-05	2	179	2	GO:0016749
GeneOntologyMolecularFunction	5-aminolevulinate synthase activity	ALAS1 ALAS2	7.99e-05	2	179	2	GO:0003870
GeneOntologyBiologicalProcess	porphyrin-containing compound metabolic process	CYP1A2 SPTB IREB2 ALAS1 ALAS2 ABCC2	1.77e-05	63	179	6	GO:0006778
GeneOntologyBiologicalProcess	tetrapyrrole metabolic process	CYP1A2 SPTB IREB2 ALAS1 ALAS2 ABCC2	4.13e-05	73	179	6	GO:0033013
GeneOntologyBiologicalProcess	protoporphyrinogen IX biosynthetic process	IREB2 ALAS1 ALAS2	5.20e-05	9	179	3	GO:0006782
GeneOntologyBiologicalProcess	kidney morphogenesis	FAT4 FRAS1 KIF26B LRRK2 LAMA5 PTCH1 KLHL3	5.24e-05	111	179	7	GO:0060993
GeneOntologyCellularComponent	growth cone	HDAC5 COPA RASGRF1 PCLO LRRK2 PTCH1 NDRG2 GDPD5 PTPRS LRP1 NIN	1.05e-05	245	182	11	GO:0030426
GeneOntologyCellularComponent	axon	CAD HDAC5 COPA RASGRF1 PPFIA2 PCLO SPTBN1 LRRK2 IREB2 GRIK5 PTCH1 NDRG2 SEPTIN8 GDPD5 CADM1 PTPRS SCN4A LRP1 AFDN LRRC7 DYNC1H1 NIN	1.07e-05	891	182	22	GO:0030424
GeneOntologyCellularComponent	site of polarized growth	HDAC5 COPA RASGRF1 PCLO LRRK2 PTCH1 NDRG2 GDPD5 PTPRS LRP1 NIN	1.42e-05	253	182	11	GO:0030427
GeneOntologyCellularComponent	distal axon	CAD HDAC5 COPA RASGRF1 PCLO LRRK2 GRIK5 PTCH1 NDRG2 GDPD5 PTPRS LRP1 NIN	1.19e-04	435	182	13	GO:0150034
GeneOntologyCellularComponent	cytoplasmic side of mitochondrial outer membrane	LRRK2 BECN1	2.25e-04	3	182	2	GO:0032473
GeneOntologyCellularComponent	basal ectoplasmic specialization	GSN KIAA1210	2.25e-04	3	182	2	GO:0061832
GeneOntologyCellularComponent	axonal growth cone	HDAC5 PTCH1 LRP1 NIN	6.27e-04	45	182	4	GO:0044295
Domain	AA_TRANSFER_CLASS_2	SPTLC3 ALAS1 ALAS2	1.78e-05	6	182	3	PS00599
Domain	CPSASE_2	CAD ACACA MCCC1	1.78e-05	6	182	3	PS00867
Domain	Aminotrans_II_pyridoxalP_BS	SPTLC3 ALAS1 ALAS2	1.78e-05	6	182	3	IPR001917
Domain	CbamoylP_synth_lsu-like_ATP-bd	CAD ACACA MCCC1	3.10e-05	7	182	3	IPR005479
Domain	BC-like_N	CAD ACACA MCCC1	3.10e-05	7	182	3	IPR005481
Domain	CPSase_L_D2	CAD ACACA MCCC1	3.10e-05	7	182	3	PF02786
Domain	Biotin_carb_N	CAD ACACA MCCC1	3.10e-05	7	182	3	PF00289
Domain	Preseq_ALAS	ALAS1 ALAS2	9.44e-05	2	182	2	PF09029
Domain	4pyrrol_synth_NH2levulA_synth	ALAS1 ALAS2	9.44e-05	2	182	2	IPR010961
Domain	5aminolev_synth_preseq	ALAS1 ALAS2	9.44e-05	2	182	2	IPR015118
Domain	EGF	FAT4 FRAS1 LAMA5 SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	1.06e-04	235	182	10	SM00181
Domain	Growth_fac_rcpt_	FAT4 FRAS1 LAMA5 SVEP1 STAB1 FAT1 CELSR1 LRP1	1.48e-04	156	182	8	IPR009030
Domain	EGF-like_dom	FAT4 FRAS1 LAMA5 SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	1.71e-04	249	182	10	IPR000742
Domain	EGF	SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	2.37e-04	126	182	7	PF00008
Domain	-	CAD ACACA MCCC1	2.42e-04	13	182	3	3.40.50.20
Domain	ATP_GRASP	CAD ACACA MCCC1	3.06e-04	14	182	3	PS50975
Domain	ATP-grasp	CAD ACACA MCCC1	3.06e-04	14	182	3	IPR011761
Domain	PreATP-grasp_dom	CAD ACACA MCCC1	3.06e-04	14	182	3	IPR016185
Domain	-	CAD ACACA MCCC1	3.80e-04	15	182	3	3.30.1490.20
Domain	LAM_G_DOMAIN	FAT4 LAMA5 FAT1 CELSR1	4.97e-04	38	182	4	PS50025
Domain	Spectrin_bsu	SPTB SPTBN1	5.59e-04	4	182	2	IPR016343
Domain	Aminotran_1_2	SPTLC3 ALAS1 ALAS2	5.60e-04	17	182	3	PF00155
Domain	Aminotransferase_I/II	SPTLC3 ALAS1 ALAS2	5.60e-04	17	182	3	IPR004839
Domain	Laminin_G_2	FAT4 LAMA5 FAT1 CELSR1	6.06e-04	40	182	4	PF02210
Domain	ATP_grasp_subdomain_1	CAD ACACA MCCC1	6.67e-04	18	182	3	IPR013815
Domain	-	CAD ACACA MCCC1	6.67e-04	18	182	3	3.30.470.20
Domain	LamG	FAT4 LAMA5 FAT1 CELSR1	8.74e-04	44	182	4	SM00282
Domain	EGF_1	FAT4 LAMA5 SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	9.12e-04	255	182	9	PS00022
Domain	Biotin_BS	ACACA MCCC1	9.26e-04	5	182	2	IPR001882
Domain	Biotin_COase_C	ACACA MCCC1	9.26e-04	5	182	2	IPR005482
Domain	BC	ACACA MCCC1	9.26e-04	5	182	2	PS50979
Domain	Biotin_carb_C	ACACA MCCC1	9.26e-04	5	182	2	SM00878
Domain	Biotin_carb_C	ACACA MCCC1	9.26e-04	5	182	2	PF02785
Domain	Biotin_carboxylation_dom	ACACA MCCC1	9.26e-04	5	182	2	IPR011764
Domain	CPSASE_1	CAD ACACA	9.26e-04	5	182	2	PS00866
Domain	BIOTIN	ACACA MCCC1	9.26e-04	5	182	2	PS00188
Domain	EGF-like_CS	FAT4 LAMA5 SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	1.07e-03	261	182	9	IPR013032
Domain	EGF_2	FAT4 LAMA5 SVEP1 STAB1 FAT1 CELSR1 WIF1 LRP1 LRP6	1.19e-03	265	182	9	PS01186
Domain	EGF_CA	FAT4 SVEP1 STAB1 FAT1 CELSR1 LRP1	1.25e-03	122	182	6	SM00179
Domain	EGF-like_Ca-bd_dom	FAT4 SVEP1 STAB1 FAT1 CELSR1 LRP1	1.36e-03	124	182	6	IPR001881
Domain	Rudment_hybrid_motif	ACACA MCCC1	1.38e-03	6	182	2	IPR011054
Domain	26S_Psome_P45	PSMC1 PSMC5	1.38e-03	6	182	2	IPR005937
Pubmed	Functional proteomics mapping of a human signaling pathway.	NPR1 VWF MAN2B1 SPTBN1 LAMA5 CBX4 PRDM4 SVEP1 DDX3X TINAGL1 ANKRD13A MTMR11 CADM1 SF3B1 LRP1 AFDN PITPNB DIAPH3 HERC1 DYNC1H1	6.16e-11	591	184	20	15231748
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 MAN2B1 ACACA TMEM94 POLR2A NOB1 LAMA5 EXTL3 ATG2A PTCH1 ANKHD1 BIRC6 RYR1 TINAGL1 ORC1 GDPD5 FAT1 CELSR1 TULP4 SH3TC1 PTPRS ARHGAP44 HERC1 DYNC1H1	5.29e-09	1105	184	24	35748872
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SECISBP2L AAMP HDAC5 COPA SEPTIN9 POLR2A NOB1 MSH5 ATG2A WDR54 LIN9 DDX3X CHUK ANKRD13A SEPTIN8 ZC3H7A EIF5B PRKAR1B PRKCI DIAPH3 BECN1 CNOT2 ANKS3	7.83e-09	1038	184	23	26673895
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAT4 ACACA KIF26B SEPTIN9 PPFIA2 TTC21A PCLO POLR2A COQ8B PSMC1 ESX1 GRIK5 ECPAS BIRC6 RYR1 DENND4B LRRC7 DYNC1H1 FBXO34	1.58e-08	736	184	19	29676528
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FAT4 CAD ACACA COPA STRBP POLR2A SPTBN1 PSMC1 LAMA5 ECPAS DDX3X DMAP1 ADGB SF3B1 RGS6 CDC16 PSPC1 STAG3 DYNC1H1	2.32e-08	754	184	19	35906200
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CAD MAN2B1 ACACA COPA STRBP SEPTIN9 PSMC1 LAMA5 GBE1 PSMC5 ERMP1 ANKHD1 BIRC6 DDX3X DMAP1 FAT1 SF3B1 EIF5B C3 PRKCI DIAPH3 CPSF3 ADPGK DYNC1H1 ALPI	2.60e-08	1297	184	25	33545068
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	CAD COPA POLR2A PSMC1 PSMC5 DDX3X SF3B1 FAF2 DYNC1H1	8.21e-08	144	184	9	35681168
Pubmed	Network organization of the human autophagy system.	RPL22 ACACA COPA SEPTIN9 PSMC1 PSMC5 ATG2A ECPAS CAMKK2 EIF5B PRKCI PRMT7 RASSF4 BECN1	1.01e-07	437	184	14	20562859
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RPL22 CAD COPA POLR2A RPS15A PSMC5 ANKHD1 DDX3X ZC3H7A SF3B1 FAF2 EIF5B C3 PSPC1 BECN1 DYNC1H1	1.51e-07	601	184	16	33658012
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL22 RALGAPA1 CAD VWF COPA SEPTIN9 PPFIA2 TTC21A PCLO SPTB SPTBN1 RPS15A PSMC1 ARHGEF12 GSN SEPTIN8 SF3B1 PTPRS ARHGAP44 OSBPL10 AFDN LRRC7 ABLIM2 PSPC1 DYNC1H1	1.69e-07	1431	184	25	37142655
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	CAD ACACA COPA STRBP SEPTIN9 POLR2A RPS15A PSMC1 PSMC5 GRIK5 ANKHD1 BIRC6 DDX3X PGM3 FAF2 PRKCI DYNC1H1	2.41e-07	704	184	17	29955894
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RALGAPA1 CAD COPA SEPTIN9 SPTBN1 RPS15A PSMC1 ARHGEF12 PSMC5 ECPAS DDX3X EIF5B LRP6 AFDN LRRC7 DIAPH3 DYNC1H1	2.60e-07	708	184	17	39231216
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	RPL22 AAMP ACACA COPA SEPTIN9 SPTBN1 PSMC1 PSMC5 MCCC1 ECPAS DDX3X GSN ANKRD13A CADM1 SF3B1 FAF2 NUDT1 LRP1 EIF5B OSBPL10 AFDN PITPNB PSPC1 CPSF3	2.80e-07	1367	184	24	32687490
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	VWF COPA SPTB SPTBN1 DEF8 NAP1L3 PSMC1 RIPK4 EXTL3 PRDM4 DDX3X DMAP1 CHUK STAB1 DGLUCY CADM1 SF3B1 WIF1 LRP1 AFDN BECN1 CNOT2 DYNC1H1	3.63e-07	1285	184	23	35914814
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	AAMP FRAS1 ACACA COPA STRBP POLR2A NOB1 ECPAS ITGAL RBM23 DDX3X SF3B1 FAF2 CDC16 PSPC1 CPSF3	4.56e-07	653	184	16	33742100
Pubmed	A population of gut epithelial enterochromaffin cells is mechanosensitive and requires Piezo2 to convert force into serotonin release.	RPL22 POLR2A PIEZO2	5.80e-07	4	184	3	30037999
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP104 RALGAPA1 LAMA5 ERMP1 ATG2A ECPAS ANKHD1 DMAP1 STAB1 SEPTIN8 CAMKK2 RBM12 ANKS3 NIN	9.96e-07	529	184	14	14621295
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	CAD MAN2B1 ACACA COPA SPTBN1 NOB1 PSMC1 LAMA5 PSMC5 DDX3X SF3B1 FAF2 PTPRS LRP1 FBXO34	1.07e-06	613	184	15	22268729
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	RPL22 CAD ACACA COPA POLR2A RPS15A PSMC1 ANKHD1 BIRC6 DDX3X SF3B1 DIAPH3 PSPC1 DYNC1H1	1.11e-06	534	184	14	35032548
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	RPL22 ACACA SPTBN1 ARHGEF12 APLP1 DDX3X GSN CHUK SF3B1 AFDN DYNC1H1	1.13e-06	317	184	11	17620599
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	RPL22 CAD ACACA COPA SEPTIN9 PCLO POLR2A SPTBN1 RPS15A MCCC1 ECPAS RYR1 DDX3X GSN FAF2 EIF5B DYNC1H1	1.57e-06	807	184	17	30575818
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FAT4 FRAS1 NPR1 MAN2B1 COPA DIPK1A PSMC1 LAMA5 ERMP1 EXTL3 GDE1 DMXL1 DMAP1 FAT1 CELSR1 CADM1 METTL9 PTPRS LRP1 LRP6 ADPGK	1.76e-06	1201	184	21	35696571
Pubmed	A cohesin-RAD21 interactome.	RPL22 CAD RPS15A PSMC1 DDX3X C3 PSPC1 PDZD2 NPAT	1.82e-06	208	184	9	22145905
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD ACACA COPA STRBP POLR2A SPTBN1 PSMC5 ECPAS ANKHD1 BIRC6 SF3B1 EIF5B AFDN CPSF3 DYNC1H1	2.33e-06	653	184	15	22586326
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CAD COPA STRBP SPTBN1 NOB1 COQ8B PSMC1 GBE1 PSMC5 EXTL3 MCCC1 ECPAS PGM3 GSN CHUK ANKRD13A SF3B1 FAF2 METTL9 AASS EIF5B DYNC1H1 ALPI	2.51e-06	1440	184	23	30833792
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL22 CAD ACACA COPA SEPTIN9 POLR2A SPTBN1 NOB1 RPS15A PSMC1 PSMC5 MCCC1 ANKHD1 BIRC6 ORC1 ZC3H7A SF3B1 FAF2 EIF5B AFDN CPSF3 DYNC1H1	3.18e-06	1353	184	22	29467282
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	RPL22 CAD ACACA COPA SEPTIN9 SPTBN1 RPS15A PSMC1 PSMC5 ECPAS ANKHD1 DDX3X GSN PHKA1 SEPTIN8 SF3B1 EIF5B AFDN PSPC1 DYNC1H1	3.37e-06	1149	184	20	35446349
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 SPTLC3 ACACA C11orf54 SEPTIN9 PPFIA2 TTC21A SPTB MSH5 ECPAS REEP3 GDE1 TULP4 SH3TC1 PTPRS ARHGAP44 LRP1 PRKAR1B PRKCI LRRC7 ABLIM2 SLC4A5 PDZD2	4.36e-06	1489	184	23	28611215
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL22 CAD ACACA COPA PCLO POLR2A SPTBN1 RPS15A PSMC1 PSMC5 ECPAS ANKHD1 DDX3X SF3B1 FAF2 CDC16 EIF5B AFDN PRKCI PSPC1 CPSF3 DYNC1H1	7.22e-06	1425	184	22	30948266
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	COPA DDX3X CDC16 DYNC1H1	7.42e-06	24	184	4	33705438
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	RPL22 ACACA COPA STRBP SEPTIN9 NOB1 RPS15A MCCC1 ANKHD1 GSN SEPTIN8 ZC3H7A EIF5B DIAPH3 NSMCE4A	8.05e-06	724	184	15	36232890
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	HDAC5 STRBP PSMC1 ARHGEF12 BIRC6 DDX3X PHKA1 ZC3H7A NIN	8.40e-06	251	184	9	29778605
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	VWF C11orf54 PPFIA2 SPTBN1 AOX1 LRRK2 ARHGEF12 LAMA5 GBE1 PSMC5 RYR1 DDX3X GSN ACE2 FAT1 SLC22A2 PRKCI DYNC1H1	8.44e-06	1016	184	18	19056867
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CAD ACACA COPA POLR2A SPTBN1 PSMC1 PSMC5 ECPAS DDX3X SF3B1 FAF2 EIF5B CPSF3 DYNC1H1	8.58e-06	638	184	14	33239621
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	HDAC5 COPA TMEM94 STRBP SEPTIN9 POLR2A SPTBN1 ARHGEF12 DMXL1 PHKA1 EIF5B C3	9.62e-06	475	184	12	31040226
Pubmed	Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.	SPTBN1 LAMA5 PSMC5 DDX3X ACE2 DYNC1H1	1.05e-05	93	184	6	38245532
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	RPL22 CAD ACACA COPA RPS15A PSMC1 PSMC5 DDX3X PGM3 FAF2 NUDT1 CPSF3 DYNC1H1	1.10e-05	565	184	13	33567341
Pubmed	Regulation of the anaphase-promoting complex by the COP9 signalosome.	PSMC1 PSMC5 CDC16	1.20e-05	9	184	3	19535905
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRAS1 HDAC5 TMEM94 SEPTIN9 ARHGEF12 CAMKK2 FAF2 DENND4B LRRC7 DYNC1H1 PDZD2	1.22e-05	407	184	11	12693553
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	RPL22 ACACA COPA SEPTIN9 SPTBN1 LAMA5 MCCC1 DDX3X GSN SF3B1 FAF2 DYNC1H1	1.26e-05	488	184	12	31324722
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CAD SPTBN1 ARHGEF12 GRIK5 DDX3X GSN SF3B1 RGS6 PTPRS ARHGAP44 LRP1 PRKAR1B AFDN PRKCI LRRC7 DYNC1H1 MTSS2	1.59e-05	963	184	17	28671696
Pubmed	Repression of rRNA transcription by PARIS contributes to Parkinson's disease.	CAD ACACA COPA RPS15A PSMC1 MCCC1 DDX3X PGM3 DYNC1H1	1.59e-05	272	184	9	25315684
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	MAN2B1 COPA SPTBN1 GBE1 BIRC6 SF3B1 EIF5B C3 PSPC1 DYNC1H1	1.65e-05	344	184	10	30333137
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	CAD ACACA COPA RPS15A PSMC1 PSMC5 MCCC1 PGM3 FAF2 DYNC1H1	1.65e-05	344	184	10	36282215
Pubmed	A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.	CAD NOB1 COQ8B BIRC6 DDX3X PHKA1 CELSR1 FAF2 AASS LRP1 CPSF3 CNOT2 ADPGK DYNC1H1	1.92e-05	686	184	14	28380382
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	CAD ACACA COPA RPS15A PSMC1 PSMC5 SF3B1 FAF2 DYNC1H1	2.06e-05	281	184	9	30455355
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	RPL22 CAD ERCC5 ACACA COPA SEPTIN9 POLR2A SPTBN1 NOB1 RPS15A PSMC1 ANKHD1 BIRC6 DDX3X GSN SF3B1 FAF2 EIF5B DIAPH3 PSPC1 DYNC1H1	2.12e-05	1415	184	21	28515276
Pubmed	Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors.	SPTBN1 DDX3X LRRC7	2.33e-05	11	184	3	39256359
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	FRAS1 CAD POLR2A SPTBN1 LAMA5 TINAGL1 LRP1 PSPC1	2.35e-05	219	184	8	31353912
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ACACA DEF8 LAMA5 IREB2 BIRC6 GSN TULP4 EIF5B ALPI NIN	2.60e-05	363	184	10	14691545
Pubmed	Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor.	LRP1 C3	2.78e-05	2	184	2	10608878
Pubmed	DDX3 directly facilitates IKKα activation and regulates downstream signalling pathways.	DDX3X CHUK	2.78e-05	2	184	2	30341167
Pubmed	The complex role of Wnt ligands in type 2 diabetes mellitus and related complications.	WIF1 LRP6	2.78e-05	2	184	2	34042263
Pubmed	Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy.	RPL22 NPR1	2.78e-05	2	184	2	38026943
Pubmed	Leucine-rich repeat kinase-2 deficiency protected against cardiac remodelling in mice via regulating autophagy formation and degradation.	LRRK2 BECN1	2.78e-05	2	184	2	35499056
Pubmed	Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk.	LRP1 LRP6	2.78e-05	2	184	2	26031789
Pubmed	Structure of a mouse erythroid 5-aminolevulinate synthase gene and mapping of erythroid-specific DNAse I hypersensitive sites.	ALAS1 ALAS2	2.78e-05	2	184	2	2780318
Pubmed	Two different genes encode delta-aminolevulinate synthase in humans: nucleotide sequences of cDNAs for the housekeeping and erythroid genes.	ALAS1 ALAS2	2.78e-05	2	184	2	2263504
Pubmed	Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.	LRRK2 LRP6	2.78e-05	2	184	2	27013965
Pubmed	The solution structure and heme binding of the presequence of murine 5-aminolevulinate synthase.	ALAS1 ALAS2	2.78e-05	2	184	2	11566198
Pubmed	Serine 254 enhances an induced fit mechanism in murine 5-aminolevulinate synthase.	ALAS1 ALAS2	2.78e-05	2	184	2	19917609
Pubmed	Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretion.	CYP1A2 GSTT1	2.78e-05	2	184	2	16406813
Pubmed	Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.	DDX3X CHUK	2.78e-05	2	184	2	25740981
Pubmed	Regulation of the 26S proteasome by adenovirus E1A.	PSMC1 PSMC5	2.78e-05	2	184	2	10970867
Pubmed	Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome.	ALAS1 ALAS2	2.78e-05	2	184	2	2347585
Pubmed	Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.	DDX3X CADM1	2.78e-05	2	184	2	23330003
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	RPL22 COPA SEPTIN9 SPTBN1 PSMC5 ERMP1 ECPAS ANKHD1 DDX3X SF3B1 AFDN C3 PSPC1 DYNC1H1	2.84e-05	711	184	14	33022573
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	ERCC5 SPTBN1 PSMC1 ECPAS DMAP1 CPSF3 ALPI NSMCE4A	2.85e-05	225	184	8	25277244
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	RPL22 PCLO SPTB SPTBN1 PSMC5 GRIK5 MCCC1 NDRG2 DDX3X GSN SEPTIN8 LRRC7 DYNC1H1	2.95e-05	621	184	13	22794259
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	RPL22 MAN2B1 ACACA COPA TTC21A RPS15A LAMA5 GBE1 CBX4 MCCC1 DDX3X TINAGL1 DGLUCY FAT1 RBM12 FAF2 METTL9 LRP1 ALAS1 PSPC1 ADPGK	3.06e-05	1451	184	21	30550785
Pubmed	The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase.	RPL22 CEP104 ACACA COPA SEPTIN9 SPTB ACE2 FAF2 CDC16 C3 FBXO34	3.26e-05	453	184	11	27113764
Pubmed	Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.	RPS15A PSMC1 PSMC5 DDX3X FAF2	3.60e-05	70	184	5	21726808
Pubmed	Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.	SEPTIN9 SPTBN1 PSMC1 PSMC5 RBM23 DDX3X SEPTIN8	3.60e-05	170	184	7	16159877
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RPL22 CAD KCNH7 ACACA SEPTIN9 PPFIA2 PCLO SPTBN1 PSMC1 MCCC1 BIRC6 SEPTIN8 SF3B1 CDC16 PRKAR1B AFDN LRRC7 CNOT2	3.82e-05	1139	184	18	36417873
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 CAD COPA POLR2A SPTBN1 PSMC1 PSMC5 BIRC6 PHKA1 MTMR11 CADM1 PTPRS LRP6 PRKCI HERC1 CPSF3 NIN	4.64e-05	1049	184	17	27880917
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	RPL22 CAD ACACA SEPTIN9 SPTBN1 RPS15A DDX3X GSN SF3B1 EIF5B DYNC1H1	5.20e-05	477	184	11	31300519
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RPL22 ACACA SEPTIN9 NOB1 PSMC1 ATG2A MCCC1 ECPAS DDX3X SEPTIN8 ZC3H7A AASS AFDN DYNC1H1 NIN	5.33e-05	853	184	15	28718761
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	HK3 HDAC5 COPA STRBP POLR2A ECPAS ANKHD1 LIN9 DMAP1 CHUK SF3B1 SH3TC1 LRP1 EIF5B DYNC1H1	5.62e-05	857	184	15	25609649
Pubmed	Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.	AAMP PCLO FAF2	6.33e-05	15	184	3	31903119
Pubmed	IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration.	ACACA PSMC5 DYNC1H1	6.33e-05	15	184	3	18303054
Pubmed	Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.	VWF ACE2 C3	6.33e-05	15	184	3	36305765
Pubmed	FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability.	STRBP PSMC1 PSMC5 DDX3X EIF5B HERC1	6.42e-05	128	184	6	28027390
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	RPL22 AAMP CAD COPA NOB1 RPS15A PSMC1 ARHGEF12 PSMC5 DDX3X SF3B1 CDC16 LRP1 EIF5B PRKCI CPSF3	6.44e-05	971	184	16	33306668
Pubmed	Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation.	STRBP POLR2A PSMC5 MCCC1 ANKHD1 SF3B1	6.71e-05	129	184	6	28973437
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	RPL22 CAD COPA SPTBN1 RPS15A PSMC1 DDX3X GSN EIF5B PSPC1 DYNC1H1 ALPI	6.72e-05	580	184	12	35676659
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDE4C ERCC5 ACACA COPA SEPTIN9 POLR2A SPTBN1 ECPAS SF3B1 ABCB9 EIF5B AFDN ALPI IQCK	7.06e-05	774	184	14	15302935
Pubmed	Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.	RPL22 CAD COPA RPS15A PSMC1 PSMC5 FAF2 DYNC1H1	7.08e-05	256	184	8	35777956
Pubmed	Putting an 'End' to HIV mRNAs: capping and polyadenylation as potential therapeutic targets.	POLR2A DDX3X CPSF3	7.75e-05	16	184	3	24330569
Pubmed	The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse Development.	VWF GYPA ALAS2	7.75e-05	16	184	3	26527618
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L AAMP HDAC5 TTC21A PSMC5 REEP3 PGM3 GSN ANKRD13A METTL9 CDC16 ARHGAP44 EIF5B AFDN C3 PRKCI CNOT2 ANKS3 DYNC1H1	8.10e-05	1321	184	19	27173435
Pubmed	Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.	SLC22A2 ABCC2	8.32e-05	3	184	2	27590272
Pubmed	Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-α.	PTCH1 C3	8.32e-05	3	184	2	35725556
Pubmed	Orphan transporter SLC6A18 is renal neutral amino acid transporter B0AT3.	SLC6A18 ACE2	8.32e-05	3	184	2	19478081
Pubmed	The clearance mechanism of chilled blood platelets.	VWF C3	8.32e-05	3	184	2	12526796
Pubmed	CircFAT1 promotes hepatocellular carcinoma progression via miR-30a-5p/REEP3 pathway.	REEP3 FAT1	8.32e-05	3	184	2	33179443
Pubmed	Expression of RA175 mRNA, a new member of the immunoglobulin superfamily, in developing mouse brain.	PTCH1 CADM1	8.32e-05	3	184	2	11711859
Pubmed	RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity.	DMAP1 RGS6	8.32e-05	3	184	2	14734556
Pubmed	Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity.	PSMC1 PSMC5	8.32e-05	3	184	2	20424172
Pubmed	Influence of polymorphism of GSTM1 gene on association between glycophorin a mutant frequency and urinary PAH metabolites in incineration workers.	GSTT1 GYPA	8.32e-05	3	184	2	11936216
Pubmed	The complete amino acid sequence for brain beta spectrin (beta fodrin): relationship to globin sequences.	SPTB SPTBN1	8.32e-05	3	184	2	8479293
Interaction	C2CD4B interactions	FAT4 FRAS1 FAT1 CELSR1 SCN4A HERC1	2.41e-06	44	179	6	int:C2CD4B
Interaction	CMA1 interactions	FAT4 FRAS1 FAT1 CELSR1 MTMR11 LRP6	3.15e-06	46	179	6	int:CMA1
Interaction	TOP3B interactions	RPL22 FRAS1 CAD MAN2B1 ACACA TMEM94 POLR2A SPTB NOB1 LAMA5 IREB2 EXTL3 ATG2A PTCH1 ANKHD1 BIRC6 RYR1 DDX3X TINAGL1 ORC1 GDPD5 ZC3H7A FAT1 CELSR1 TULP4 SH3TC1 PTPRS ARHGAP44 HERC1 CNOT2 DYNC1H1	5.63e-06	1470	179	31	int:TOP3B
Interaction	COPB1 interactions	CAD HDAC5 ACACA COPA SPTBN1 PSMC1 RIPK4 ACE2 ZC3H7A SF3B1 NUDT1 EIF5B	1.32e-05	294	179	12	int:COPB1
Interaction	FGF11 interactions	RPL22 STRBP PSMC1 PSMC5 ANKHD1 DDX3X EIF5B PRKAR1B HERC1	2.18e-05	170	179	9	int:FGF11
Interaction	KCNA3 interactions	RALGAPA1 CAD COPA SEPTIN9 SPTBN1 LRRK2 RPS15A PSMC1 ARHGEF12 PSMC5 ECPAS RYR1 DDX3X ORC1 FAF2 EIF5B LRP6 AFDN LRRC7 DIAPH3 DYNC1H1	3.24e-05	871	179	21	int:KCNA3
Interaction	PSMD1 interactions	CAD HDAC5 ACACA RPS15A PSMC1 KLF15 PSMC5 PTCH1 ECPAS ACE2 RBM12 PTPRS AFDN PRKCI	4.27e-05	442	179	14	int:PSMD1
Coexpression	GSE20715_0H_VS_24H_OZONE_LUNG_DN	LRRK2 KLF15 SVEP1 GSN TINAGL1 TULP4 EIF5B C3 ALAS1	1.16e-05	200	182	9	M4367
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	VWF SPTBN1 PTCH1 NDRG2 LIN9 GSN STAB1 CADM1 C3 ALAS2 SLC4A5 MTSS2	4.22e-05	422	182	12	M7396
Coexpression	TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL	NPR1 SPTBN1 AOX1 SVEP1 PGM3 GSN PTPRS LRP1 C3 ITM2A	4.49e-05	296	182	10	M41675
Coexpression	GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	ARHGEF12 DMXL1 ZC3H7A PIEZO2 SF3B1 HERC1 STAG3	4.99e-05	137	182	7	M6346
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN	RPL22 FAT4 SLC29A3 VWF MAN2B1 RASGRF1 DEF8 GSN STAB1 KLHL3 CELSR1 FAM153A SH3TC1 LRP1 SLC37A2 IQCK	6.31e-05	740	182	16	M41202
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	VWF SPTBN1 PTCH1 NDRG2 LIN9 GSN STAB1 CADM1 C3 ALAS2 SLC4A5 MTSS2	6.86e-05	444	182	12	MM1051
Coexpression	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	FRAS1 HDAC5 LAMA5 CBX4 ATG2A KLHL3 DGLUCY PSPC1	7.14e-05	196	182	8	M4532
Coexpression	GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	HDAC5 RPS15A CBX4 ATG2A PRDM4 KLHL3 DGLUCY PSPC1	7.14e-05	196	182	8	M4530
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	ERCC5 PSMC5 CBX4 SH3TC1 DENND4B AFDN RASSF4 NSMCE4A	7.94e-05	199	182	8	M9964
Coexpression	GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	CAD NOB1 PSMC1 ORC1 CDC16 SCN4A ALAS1 NPAT	8.22e-05	200	182	8	M9474
Coexpression	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	RPS15A KLF15 IREB2 DMAP1 AASS PRKCI ALAS2 ADPGK	8.22e-05	200	182	8	M7055
Coexpression	GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	RPL22 MAN2B1 SEPTIN9 MSH5 GSN STAB1 AASS C3	8.22e-05	200	182	8	M5104
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L SPTLC3 ACACA MCCC1 CELSR1 CADM1 ARHGAP44 LRP6 PRKCI PDZD2	1.12e-08	199	184	10	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 LAMA5 CAPN13 CADM1 ARHGAP44 OSBPL10 AFDN DIAPH3 PDZD2	1.02e-07	190	184	9	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA LRRK2 CELSR1 CADM1 ARHGAP44 WIF1 LRP6 B4GALNT3 PDZD2	1.07e-07	191	184	9	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ACACA LRRK2 CELSR1 CADM1 ARHGAP44 WIF1 PRKCI B4GALNT3 PDZD2	1.12e-07	192	184	9	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ACACA LRRK2 CELSR1 CADM1 ARHGAP44 LRP6 PRKCI B4GALNT3 PDZD2	1.12e-07	192	184	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPTLC3 ACACA RASGRF1 LRRK2 MCCC1 CADM1 ARHGAP44 PRKCI PDZD2	1.52e-07	199	184	9	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	PDE4C ACACA LAMA5 PGM3 DMXL1 LRP6 DIAPH3 CHAC1	1.66e-07	145	184	8	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	PDE4C ACACA LAMA5 PGM3 DMXL1 LRP6 DIAPH3 CHAC1	1.66e-07	145	184	8	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	HDAC5 KIF26B SPTB PTCH1 ECPAS SEPTIN8 PTPRS ABLIM2	5.11e-07	168	184	8	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 LAMA5 CAPN13 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.02e-06	184	184	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ACACA RASGRF1 LRRK2 CADM1 ARHGAP44 WIF1 C3 PDZD2	1.02e-06	184	184	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 LAMA5 CAPN13 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.02e-06	184	184	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 TTC21A GBE1 NDRG2 RNASE10 C3 ALAS1 HSD17B1	1.06e-06	185	184	8	53854a9ec87c24c360541c83d86d8fafb303ad58
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 TTC21A GBE1 NDRG2 RNASE10 C3 ALAS1 HSD17B1	1.06e-06	185	184	8	a61fc7a3700a1efcf640bef7680c0443ee148a46
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SECISBP2L STRBP LRRK2 CELSR1 CADM1 ARHGAP44 WIF1 PRKCI	1.10e-06	186	184	8	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A18 SPTLC3 AOX1 CELSR1 SLC22A2 ABCC2 RASSF4 PDZD2	1.10e-06	186	184	8	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SECISBP2L FRAS1 LAMA5 CELSR1 CADM1 ARHGAP44 WIF1 DIAPH3	1.15e-06	187	184	8	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SECISBP2L FRAS1 STRBP LRRK2 CADM1 ARHGAP44 WIF1 PRKCI	1.29e-06	190	184	8	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1 PDZD2	1.35e-06	191	184	8	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SECISBP2L LRRK2 LAMA5 CADM1 ARHGAP44 WIF1 AFDN PRKCI	1.35e-06	191	184	8	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	SECISBP2L ACACA RASGRF1 PCLO LRRK2 MCCC1 WIF1 PRKCI	1.40e-06	192	184	8	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L ACACA RASGRF1 LRRK2 CADM1 WIF1 C3 PRKCI	1.45e-06	193	184	8	043dd0fc2f93e0bd1ca34ac3e196622b3e91df0f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1 C3 PDZD2	1.45e-06	193	184	8	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	IPF-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	NPR1 AOX1 GBE1 SVEP1 GSN LRP1 C3 ITM2A	1.51e-06	194	184	8	da3e1d39575969a069ef43e552afe94b2f441d0b
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SPTLC3 RASGRF1 LRRK2 CADM1 WIF1 C3 PDZD2	1.63e-06	196	184	8	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L SPTLC3 ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1	1.76e-06	198	184	8	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L SPTLC3 ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1	1.76e-06	198	184	8	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACACA STRBP MCCC1 CELSR1 CADM1 ARHGAP44 PRKCI PDZD2	1.83e-06	199	184	8	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L LRRK2 MCCC1 CADM1 WIF1 LRP6 C3 PDZD2	1.83e-06	199	184	8	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAN2B1 HK3 GSN STAB1 SH3TC1 SLC37A2 C3 RASSF4	1.90e-06	200	184	8	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	droplet-Heart-nan-24m-Hematologic-red_blood_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAD PDE4C HEXD GYPA ALAS2	3.49e-06	56	184	5	55337ff90621e1fea4d747ae2559c0fa61b38dce
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR54 PTCH1 ITGAL SLC7A14 RYR1 OSGIN2 ADPGK	4.90e-06	161	184	7	3f3a2148c8d65e6a06f8d8116a3aa58dda17d618
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB ARHGEF12 APLP1 GYPA LRP1 ALAS2 ABLIM2	4.90e-06	161	184	7	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	Smart-seq2-blood_(Smart-seq2)\|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HK3 LRRK2 STAB1 DENND4B LRP1 ALAS2 RASSF4	6.73e-06	169	184	7	0ee74cc97a2db9cc16dc73424f74747afe13af90
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	VWF SPTBN1 ARHGEF12 LAMA5 CADM1 ARHGAP44 PDZD2	7.00e-06	170	184	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	droplet-Spleen-SPLEEN\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 TINAGL1 SEPTIN8 METTL9 GYPA C3 ALAS2	7.55e-06	172	184	7	d32731a56e113ff0ef7167b23959d69baf2068f9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A18 AOX1 ACE2 RGN ABCC2 RASSF4 PDZD2	8.77e-06	176	184	7	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLF15 NDRG2 SVEP1 GSN GSTT1 LRP1 C3	1.05e-05	181	184	7	091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACACA GDE1 CADM1 ARHGAP44 WIF1 C3 B4GALNT3	1.05e-05	181	184	7	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SPTB ARHGEF12 ATG2A RGS6 GYPA ALAS2 HERC1	1.09e-05	182	184	7	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FRAS1 AOX1 ACE2 FAT1 SLC22A2 OSBPL10 ABCC2	1.13e-05	183	184	7	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 KIF26B PPFIA2 PCLO FAT1 PIEZO2	1.17e-05	184	184	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 KIF26B PPFIA2 PCLO FAT1 PIEZO2	1.17e-05	184	184	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	SPTBN1 LAMA5 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.17e-05	184	184	7	561592edc3083fad41b91811151b442207c65dd9
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	AOX1 LRRK2 ACE2 FAT1 SLC22A2 OSBPL10 RASSF4	1.17e-05	184	184	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 KIF26B PPFIA2 PCLO FAT1 PIEZO2	1.17e-05	184	184	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 LAMA5 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.21e-05	185	184	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A2 KLF15 SVEP1 GSTT1 ARHGAP44 LRP1 C3	1.21e-05	185	184	7	eaa54b76743628c89b4310be57b87fa92b75fd37
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A2 KLF15 SVEP1 GSTT1 ARHGAP44 LRP1 C3	1.21e-05	185	184	7	ff38a15af3dec36d9993f06623591872b5d1da9a
ToppCell	droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 GBE1 SLC7A14 GSN C3 ALAS1 ADPGK	1.21e-05	185	184	7	3dcafbd02b65a2befbb6e6288cb2591e721cddb6
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A2 KLF15 SVEP1 GSTT1 ARHGAP44 LRP1 C3	1.21e-05	185	184	7	f7f4c921d248c637351e2e882589b99ba7f04b66
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF STAB1 TINAGL1 GDPD5 SH3TC1 ITM2A	1.30e-05	187	184	7	03de3c2df31bca0dc4e3718bada708d8fe8b69b9
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE4C RASGRF1 C11orf54 LRRK2 LRRC52 CADM1 WIF1	1.30e-05	187	184	7	7c44cec1c26ca5907a495f2d7e633410e2e9728f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	SPTBN1 LAMA5 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.30e-05	187	184	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEPTIN9 ANKRD13A CADM1 ARHGAP44 WIF1 AFDN B4GALNT3	1.35e-05	188	184	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ACACA RASGRF1 PCLO LRRK2 AASS ARHGAP44 C3	1.35e-05	188	184	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA5 CELSR1 CADM1 ARHGAP44 WIF1 AFDN DIAPH3	1.35e-05	188	184	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	SPTBN1 LAMA5 CADM1 ARHGAP44 AFDN DIAPH3 PDZD2	1.39e-05	189	184	7	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF26B AOX1 PTCH1 SVEP1 PIEZO2 PTPRS LRP1	1.39e-05	189	184	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	AOX1 FAT1 SLC22A2 OSBPL10 C3 ABCC2 RASSF4	1.39e-05	189	184	7	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACACA RASGRF1 LRRK2 CADM1 ARHGAP44 WIF1 C3	1.44e-05	190	184	7	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AOX1 CELSR1 SLC22A2 OSBPL10 ABCC2 RASSF4 PDZD2	1.49e-05	191	184	7	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L RPL22 RASGRF1 LRRK2 RPS15A CADM1 WIF1	1.49e-05	191	184	7	2b0d55a8e1b4ce862dd038f8e0429e8428fb8aba
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AOX1 CELSR1 SLC22A2 OSBPL10 ABCC2 RASSF4 PDZD2	1.49e-05	191	184	7	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ACACA RASGRF1 PCLO LRRK2 CADM1 ARHGAP44 C3	1.49e-05	191	184	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L PPFIA2 APLP1 REEP3 SLC7A14 SEPTIN8 PIEZO2	1.54e-05	192	184	7	8dc3016601148243196e925641c9507e9d58c9e0
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 NPR1 ARHGEF12 TBC1D20 RGS6 AFDN ITM2A	1.54e-05	192	184	7	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1 PDZD2	1.54e-05	192	184	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1	1.60e-05	193	184	7	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	facs-Lung-EPCAM-18m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF15 NDRG2 SVEP1 GSN GSTT1 LRP1 C3	1.60e-05	193	184	7	b9ac74357435f2f24aaede62b2a1d31b5d96a12c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L ACACA RASGRF1 LRRK2 MCCC1 CADM1 WIF1	1.60e-05	193	184	7	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	facs-Heart-RV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF15 NDRG2 SVEP1 GSN GSTT1 LRP1 ITM2A	1.60e-05	193	184	7	76f0f8569255d6cdf1e3b8e954cae72e71f87157
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 NPR1 VWF ARHGEF12 RGS6 AFDN ITM2A	1.60e-05	193	184	7	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 NPR1 VWF ARHGEF12 RGS6 AFDN ITM2A	1.60e-05	193	184	7	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA LRRK2 CADM1 ARHGAP44 WIF1 AFDN PDZD2	1.65e-05	194	184	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L ACACA LRRK2 MCCC1 CADM1 WIF1 PDZD2	1.65e-05	194	184	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L RASGRF1 LRRK2 MCCC1 CADM1 WIF1 C3	1.65e-05	194	184	7	46266d3d9af7000dc1381b1c8e55047193cbcf94
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF TINAGL1 GDPD5 RGS6 SH3TC1 ITM2A	1.65e-05	194	184	7	2e3a64bda7c76fd0c99e93de0215f236e8045d83
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPTBN1 SVEP1 GSN GSTT1 LRP1 C3 ITM2A	1.65e-05	194	184	7	889c6e231bdd5b59902c7d2afdc077360b1d3256
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 AOX1 APLP1 EXTL3 C3 ABLIM2 CHAC1	1.71e-05	195	184	7	a52685f76eca269a7d2de8dfc317439483e233fa
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF TINAGL1 GDPD5 RGS6 SH3TC1 ITM2A	1.71e-05	195	184	7	ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6
ToppCell	PCW_07-8.5-Endothelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF TINAGL1 GDPD5 RGS6 SH3TC1 ITM2A	1.71e-05	195	184	7	f2cc94d5e1652203ca38bea57f37d3deec73ef04
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 AOX1 APLP1 EXTL3 C3 ABLIM2 CHAC1	1.71e-05	195	184	7	224deeba2f60def6543a55bb4f5ee6c7fdab3f02
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 AOX1 SVEP1 GSN PIEZO2 LRP1 C3	1.71e-05	195	184	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA LRRK2 CADM1 ARHGAP44 WIF1 AFDN PDZD2	1.71e-05	195	184	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 KIF26B PTCH1 SVEP1 PIEZO2 ALX1 LRP1	1.76e-05	196	184	7	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SECISBP2L RASGRF1 LRRK2 CADM1 WIF1 LRP6 C3	1.76e-05	196	184	7	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 KIF26B PTCH1 SVEP1 PIEZO2 ALX1 LRP1	1.76e-05	196	184	7	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF STAB1 TINAGL1 GDPD5 RGS6 ITM2A	1.76e-05	196	184	7	81278e696d823744267d6315c4d42799c4ea0b2c
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RPL22 RASGRF1 LRRK2 RPS15A CADM1 WIF1 C3	1.76e-05	196	184	7	fa42a8f8a11645fc733ce9c59c2a0599ecf2176d
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPA SPTBN1 ARHGEF12 DDX3X SF3B1 WIF1 ITM2A	1.82e-05	197	184	7	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NPR1 VWF STAB1 TINAGL1 GDPD5 RGS6 ITM2A	1.82e-05	197	184	7	88859b7b24b36afab4a684fd7abf0e0f8e5b525c
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA SPTBN1 ARHGEF12 DDX3X SF3B1 WIF1 ITM2A	1.82e-05	197	184	7	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L PDE4C RASGRF1 LRRK2 CADM1 WIF1 C3	1.82e-05	197	184	7	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	ASK440-Epithelial-Type_2\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SECISBP2L ACACA RASGRF1 LRRK2 CADM1 WIF1 C3	1.82e-05	197	184	7	08d5bbeb77a4152af1c783bc958afcae24667767
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	SECISBP2L SPTLC3 RASGRF1 LRRK2 CADM1 WIF1 C3	1.82e-05	197	184	7	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L RASGRF1 APLP1 SLC7A14 GSN SEPTIN8 PIEZO2	1.82e-05	197	184	7	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	RPL22 SPTBN1 RPS15A PTCH1 NDRG2 RGN PIEZO2	1.82e-05	197	184	7	44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH7 STRBP PPFIA2 PCLO ARHGAP44 LRRC7 HERC1	1.88e-05	198	184	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 VWF SPTBN1 GSN TINAGL1 ITM2A IQCK	1.94e-05	199	184	7	57709dc893da8d9333830b8277a6d92e25aa8bc0
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; PC3; HT_HG-U133A	RALGAPA1 ECPAS SVEP1 TINAGL1 CADM1 ABCB9 AASS C3 ABCC2 MTSS2	4.42e-06	196	183	10	4574_UP
Drug	Amiodarone	SLC6A18 CYP1A2 FRAS1 CAD MAN2B1 ACACA PPDPF SPTBN1 PSMC1 KLF15 GBE1 PSMC5 ECPAS NDRG2 GSN PHKA1 GSTT1 RGN FAT1 FAM153A RGS6 ABCB9 SLC22A2 SCN4A ALAS1 ALAS2 ABCC2 ADPGK CHAC1	6.40e-06	1469	183	29	ctd:D000638
Drug	uroporphyrin III	CYP1A2 LPO ALAS1 ALAS2	6.82e-06	16	183	4	CID000072423
Drug	BAMP	NPR1 ACACA MCCC1	1.00e-05	6	183	3	CID000440839
Drug	2alpha-propoxy-1alpha,25-dihydroxyvitamin D3	SPTBN1 RYR1 C3	1.00e-05	6	183	3	CID010062706
Drug	heptacarboxylic porphyrin	CYP1A2 ALAS1 ALAS2	1.75e-05	7	183	3	CID000168414
Drug	naphthol AS-D chloroacetate	VWF ITGAL PGM3 GYPA LPO ALPI	2.31e-05	71	183	6	CID000160247
Drug	oxothulium	CYP1A2 RASGRF1 ALAS1 ALAS2	2.64e-05	22	183	4	CID000139299
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A	RALGAPA1 FAT4 DIPK1A EXTL3 TINAGL1 CADM1 ABCB9 IQCK MTSS2	2.74e-05	193	183	9	6699_DN
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A	NPR1 RASGRF1 GRIK5 RYR1 ADGB RGS6 SLC22A2 RASSF4 ALPI	2.86e-05	194	183	9	4260_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	RALGAPA1 NPR1 RASGRF1 ARHGEF12 SLC22A2 LPO SCN4A PRKAR1B MTSS2	2.97e-05	195	183	9	2394_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A	HDAC5 TMEM94 IREB2 SEPTIN8 KLHL3 CELSR1 ANKEF1 LRP6 CHAC1	3.10e-05	196	183	9	7142_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CEP104 PPDPF PCLO ORC1 SEPTIN8 RBM12 DENND4B PRMT7 PDZD2	3.22e-05	197	183	9	1224_DN
Drug	Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ATG2A PTCH1 ABCB9 PTPRS ARHGAP44 PRKAR1B C3 HSD17B1 OSGIN2	3.22e-05	197	183	9	2821_UP
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	RALGAPA1 PCLO PTCH1 SVEP1 RYR1 DDX3X GSN RBM12 MTSS2	3.22e-05	197	183	9	4730_UP
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; HL60; HT_HG-U133A	PCLO SPTB RYR1 DDX3X STAB1 GSTT1 CAMKK2 PRKAR1B MTSS2	3.22e-05	197	183	9	2488_UP
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	CEP104 RALGAPA1 APLP1 GRIK5 EXTL3 GDPD5 GYPA PRKAR1B LRP6	3.35e-05	198	183	9	5389_DN
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A	CEP104 SPTLC3 TMEM94 SPTBN1 IREB2 APLP1 KLHL3 OSGIN2 CHAC1	3.35e-05	198	183	9	5869_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	RALGAPA1 HDAC5 SEPTIN9 APLP1 ECPAS GDPD5 PTPRS PRKAR1B LRP6	3.35e-05	198	183	9	5393_DN
Drug	HNMPA-(AM)3; Up 200; 5uM; PC3; HG-U133A	SLC29A3 KLF15 GRIK5 NDRG2 PIEZO2 CADM1 PRKAR1B CHAC1 IQCK	3.49e-05	199	183	9	583_UP
Drug	ethylhydrazine	CYP1A2 NPR1 LPO	4.14e-05	9	183	3	CID000029062
Drug	Maprotiline	SLC22A2 ABCC2 BECN1	4.14e-05	9	183	3	ctd:D008376
Drug	dicyclohexyl phthalate	CYP1A2 CAD HDAC5 STRBP SPTB AOX1 LRRK2 ARHGEF12 KLF15 RIPK4 GSN STAB1 GSTT1 RGN C3 PRKCI HSD17B1 BECN1 ALPI	4.66e-05	836	183	19	ctd:C036042
Drug	phenylhydrazine	NPR1 SPTB SPTBN1 LPO ALAS1 ALAS2	5.24e-05	82	183	6	CID000007516
Drug	mannose-1-phosphate	MAN2B1 HK3 GBE1 IREB2 PGM3 PHKA1 DYNC1H1 ALPI	5.86e-05	165	183	8	CID000000466
Drug	2-amino-3-ketoadipate	ALAS1 ALAS2	6.43e-05	2	183	2	CID000440714
Drug	pregnanedione	ALAS1 ALAS2	6.43e-05	2	183	2	CID000135006
Drug	LY188544	PTCH1 C3	6.43e-05	2	183	2	CID000126157
Disease	cancer (is_implicated_in)	LRRK2 GSTT1	3.66e-05	2	179	2	DOID:162 (is_implicated_in)
Disease	cathepsin L1 measurement	MAN2B1 LRRK2 ADGB	1.16e-04	16	179	3	EFO_0010619
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTB SPTBN1	2.18e-04	4	179	2	DOID:0050882 (implicated_via_orthology)
Disease	neurodegenerative disease (implicated_via_orthology)	FAT4 LRRK2 PSMC1 PTCH1 MTMR11 DYNC1H1	2.65e-04	145	179	6	DOID:1289 (implicated_via_orthology)
Disease	COVID-19 (is_implicated_in)	GSTT1 ACE2 C3	2.69e-04	21	179	3	DOID:0080600 (is_implicated_in)
Disease	porphyria (implicated_via_orthology)	GBE1 IREB2	3.62e-04	5	179	2	DOID:13268 (implicated_via_orthology)
Disease	disease progression measurement	SLC29A3 POLR2A CELSR1 HERC1	5.22e-04	61	179	4	EFO_0008336
Disease	Paratuberculosis	GSN C3	5.40e-04	6	179	2	C0030524
Disease	anemia (biomarker_via_orthology)	IREB2 ALAS2	7.53e-04	7	179	2	DOID:2355 (biomarker_via_orthology)
Disease	bilirubin metabolic disorder (biomarker_via_orthology)	ALAS2 ABCC2	7.53e-04	7	179	2	DOID:2741 (biomarker_via_orthology)
Disease	fasting blood insulin measurement	SLC29A3 KIF26B SPTB MCCC1	8.33e-04	69	179	4	EFO_0004466
Disease	Drug-Induced Liver Disease	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C0860207
Disease	Drug-Induced Acute Liver Injury	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C3658290
Disease	Hepatitis, Toxic	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C0019193
Disease	Chemically-Induced Liver Toxicity	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C4279912
Disease	Chemical and Drug Induced Liver Injury	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C4277682
Disease	Hepatitis, Drug-Induced	CYP1A2 VWF MCCC1 GSN GSTT1 RGN AASS C3 ABCC2	8.51e-04	404	179	9	C1262760
Disease	Hereditary spherocytosis	CAD SPTB	1.00e-03	8	179	2	C0037889
Disease	non-small cell lung carcinoma	SECISBP2L CYP1A2 MSH5 PIEZO2	1.14e-03	75	179	4	EFO_0003060
Disease	lysine measurement	TINAGL1 RGS6 AASS	1.47e-03	37	179	3	EFO_0005002
Disease	leptin measurement	SPTB MCCC1 ADGB PDZD2	1.51e-03	81	179	4	EFO_0005000
Disease	Carotid Circulation Transient Ischemic Attack	NDRG2 C3	1.59e-03	10	179	2	C0751019
Disease	Transient Ischemic Attack	NDRG2 C3	1.59e-03	10	179	2	C0007787
Disease	Crescendo Transient Ischemic Attacks	NDRG2 C3	1.59e-03	10	179	2	C0751021
Disease	Transient Ischemic Attack, Vertebrobasilar Circulation	NDRG2 C3	1.59e-03	10	179	2	C0751020
Disease	Brain Stem Ischemia, Transient	NDRG2 C3	1.59e-03	10	179	2	C0751022
Disease	theophylline measurement	CYP1A2 LRRK2	1.59e-03	10	179	2	EFO_0021180
Disease	Posterior Circulation Transient Ischemic Attack	NDRG2 C3	1.59e-03	10	179	2	C0472381
Disease	1,7-dimethylurate measurement	CYP1A2 GRIK5	1.59e-03	10	179	2	EFO_0021512
Disease	Transient Ischemic Attack, Anterior Circulation	NDRG2 C3	1.59e-03	10	179	2	C1527335
Disease	Transient Cerebral Ischemia	NDRG2 C3	1.59e-03	10	179	2	C0917805
Disease	Intellectual Disability	RALGAPA1 TMEM94 DDX3X PGM3 TBC1D20 ACE2 ALKBH8 AASS DYNC1H1	1.71e-03	447	179	9	C3714756
Disease	invasive ductal carcinoma (is_marker_for)	WIF1 PRKCI HSD17B1	1.84e-03	40	179	3	DOID:3008 (is_marker_for)
Disease	peanut allergy measurement, parental genotype effect measurement	RYR1 ADGB	1.94e-03	11	179	2	EFO_0005939, EFO_0007017
Disease	Basal cell carcinoma	ERCC5 PTCH1	1.94e-03	11	179	2	C0007117
Disease	Congenital small ears	FRAS1 ORC1 WIF1	1.98e-03	41	179	3	C0152423
Disease	oral microbiome measurement	FRAS1 GRIK5 PDZD2	2.12e-03	42	179	3	EFO_0801229
Disease	Congenital myopathy (disorder)	RYR1 SCN4A	2.32e-03	12	179	2	C0270960
Disease	Squamous cell carcinoma of esophagus	FAT4 GSTT1 FAT1 ABCC2	2.71e-03	95	179	4	C0279626
Disease	response to radiation, hearing loss, response to antineoplastic agent	RNASE10 LRRC7 PDZD2	2.75e-03	46	179	3	EFO_0004238, GO_0009314, GO_0097327
Disease	pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio	PTCH1 GYPA LRP1	2.93e-03	47	179	3	EFO_0003892, EFO_0004713, EFO_0005671
Disease	myocardial infarction (biomarker_via_orthology)	VWF GSN ACE2 C3 BECN1	2.99e-03	160	179	5	DOID:5844 (biomarker_via_orthology)
Disease	hippocampal CA1 volume	STRBP PTCH1 FBXO34	3.11e-03	48	179	3	EFO_0009394
Disease	thalamus volume change measurement	KIF26B FAT1	3.17e-03	14	179	2	EFO_0021496
Disease	revision of total hip arthroplasty	RIPK4 OSBPL10	3.17e-03	14	179	2	EFO_0020973
Disease	5-methyluridine (ribothymidine) measurement	PCLO PTPRS	3.17e-03	14	179	2	EFO_0020013
Disease	Anilide use measurement	MSH5 LRP1	3.65e-03	15	179	2	EFO_0009938
Disease	1,3,7-trimethylurate measurement	CYP1A2 FRAS1	3.65e-03	15	179	2	EFO_0021172
Disease	anemia (implicated_via_orthology)	IREB2 SLC4A5	3.65e-03	15	179	2	DOID:2355 (implicated_via_orthology)
Disease	inflammatory biomarker measurement, YKL40 measurement	PTCH1 SLC39A12 METTL9	3.69e-03	51	179	3	EFO_0004869, EFO_0004872
Disease	Colorectal Carcinoma	CYP1A2 CAD HK3 ACACA PSMC5 FAT1 SH3TC1 PTPRS WIF1 LRP1 ABCC2	3.87e-03	702	179	11	C0009402
Disease	pulmonary function measurement, FEV/FEC ratio	PTCH1 GYPA LRP1	4.12e-03	53	179	3	EFO_0003892, EFO_0004713
Disease	Schizoaffective disorder-bipolar type	PCLO PTCH1	4.15e-03	16	179	2	EFO_0009965
Disease	sickle cell anemia (is_implicated_in)	GSTT1 C3	4.15e-03	16	179	2	DOID:10923 (is_implicated_in)
Disease	mortality	PSMC1 CADM1 PITPNB PDZD2 NIN	4.17e-03	173	179	5	EFO_0004352
Disease	hepatocellular carcinoma (biomarker_via_orthology)	CAD RGN CADM1 C3	4.30e-03	108	179	4	DOID:684 (biomarker_via_orthology)
Disease	Glycogen storage disease	GBE1 PHKA1	4.69e-03	17	179	2	cv:C0017919
Disease	Kuhnt-Junius degeneration (is_implicated_in)	GSTT1 C3	4.69e-03	17	179	2	DOID:10873 (is_implicated_in)
Disease	diabetic neuropathy (biomarker_via_orthology)	LRRK2 BECN1	4.69e-03	17	179	2	DOID:9743 (biomarker_via_orthology)
Disease	hypertrophic cardiomyopathy (is_marker_for)	ACE2 BECN1	4.69e-03	17	179	2	DOID:11984 (is_marker_for)
Disease	MHPG measurement, 5-HIAA measurement	PIEZO2 CADM1	4.69e-03	17	179	2	EFO_0005132, EFO_0005133
Disease	urate measurement, bone density	SPTLC3 FRAS1 PPFIA2 LAMA5 GBE1 RIPK4 RGS6 PRKAR1B PITPNB PDZD2	4.70e-03	619	179	10	EFO_0003923, EFO_0004531
Disease	Alzheimer's disease (implicated_via_orthology)	PSMC5 APLP1 LRP1	5.05e-03	57	179	3	DOID:10652 (implicated_via_orthology)
Disease	drug-Induced dyskinesia, response to levodopa	EXTL3 CAPN13	5.25e-03	18	179	2	EFO_0010747, EFO_1000904
Disease	kidney volume	PTCH1 GYPA	5.25e-03	18	179	2	EFO_0600044
Disease	lifestyle measurement, alcohol consumption measurement	VWF GRIK5 PIEZO2 RGS6	5.37e-03	115	179	4	EFO_0007878, EFO_0010724
Disease	Malignant neoplasm of skin	PTCH1 GSTT1 GYPA	5.56e-03	59	179	3	C0007114
Disease	Skin Neoplasms	PTCH1 GSTT1 GYPA	5.56e-03	59	179	3	C0037286
Disease	inflammatory bowel disease (is_implicated_in)	GSTT1 ALPI	5.85e-03	19	179	2	DOID:0050589 (is_implicated_in)
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	VWF GSTT1	5.85e-03	19	179	2	DOID:9744 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HAPSIIFMDEIDSIG	PSMC5	241	P62195
GPLEHVMETLDNESF	ALX1	26	Q15699
SQPTEDLEFHGVMRF	AFDN	31	P55196
TATADLAHPLDMFLG	ESX1	206	Q8N693
TIGVMVTASHNPEED	PGM3	56	O95394
EEFQPDLVVLSGLHM	ADPGK	251	Q9BRR6
VFEFVGEPELMDVHV	NUDT1	71	P36639
GEPELMDVHVFCTDS	NUDT1	76	P36639
SLHDDGFTVPQIIEM	BIRC6	656	Q9NR09
LKSMDHFDDIGPSVV	CPSF3	311	Q9UKF6
SMEGPDDSEVTFALH	AAMP	76	Q13685
ETFLQMDEVGHIPQT	B4GALNT3	286	Q6L9W6
SMVSFVIGDEHVVLP	ADGB	766	Q8N7X0
SEIVMDFKHPDGIAV	ALKBH8	256	Q96BT7
MVQPDFELHAISGEI	FAT4	1141	Q6V0I7
EMTDELVGLPFSSHT	FBXO34	406	Q9NWN3
GSIEFMTECTTIEHP	AASS	361	Q9UDR5
AISHGVVEVDPMLTL	APLP1	611	P51693
TMVLEAHDAQGDVPV	C3	41	P01024
APATIATPAVFEHME	ACACA	391	Q13085
IDMVSFLLDLGAHPD	ANKEF1	61	Q9NU02
HLSPEEFQEVFGMSI	ABLIM2	576	Q6H8Q1
AMFICSEIPITLDHG	CAPN13	326	Q6MZZ7
PLEALMEVSVSDGIH	CELSR1	1171	Q9NYQ6
EVSHGPSDVESVMLS	CELSR1	1751	Q9NYQ6
MEDGLVNTIPASFHD	NPR1	341	P16066
EMVALSDNIPAGVTH	C7orf31	376	Q8N865
SQIVLHRDGMDPDFT	DIAPH3	466	Q9NSV4
MEDSGLFEAAHVLSP	DMXL1	1306	Q9Y485
VSEEHPEGMVTVAIA	ERMP1	851	Q7Z2K6
GELVLDMEHGTLFSV	ATG2A	956	Q2TAZ0
LADSEVEPSVIGHMS	ARHGEF12	156	Q9NZN5
PGVVDIMTAEHLSDV	AOX1	636	Q06278
TMDIRHFFSGLTIPD	RBM12	16	Q9NTZ6
HFNITEDMLRGIFEP	RBM23	271	Q86U06
FLMEADLGVEVPHEV	RASSF4	256	Q9H2L5
DILAHEAMGDTFPDA	RLN3	56	Q8WXF3
PISDHVLTMKDDGTF	RGS6	96	P49758
GQHFPESSDEMLSLV	CYP1A2	206	P05177
ITVAPVEEMLFHGFS	IQCK	81	Q8N0W5
LFPDSVVGTDSHITM	IREB2	271	P48200
PFMATVLESAEHSEP	PPDPF	66	Q9H3Y8
DEFLGLPSEIHMSEE	NPAT	296	Q14207
TVLHEAVSTGDPEMV	ANKRD13A	76	Q8IZ07
PPHIESFSDVEMGEI	DDX3X	176	O00571
DAPVGSLVMTVSAHD	FAT1	1046	Q14517
LDVHEENIPTVMSAG	NXF3	251	Q9H4D5
IMITHFEPSISFEGL	PRKCI	36	P41743
MAPVEHVVADAGAFL	NOB1	1	Q9ULX3
VSDGEHTSPEMVLTI	FRAS1	1571	Q86XX4
VLSNEPHETMPIAAF	LIN9	271	Q5TKA1
PKIVAFETVHSMDGA	ALAS1	376	P13196
FETVHSMDGAVCPLE	ALAS1	381	P13196
GHSDVVLVDTMDELP	MTMR11	296	A4FU01
VEDSFVHPANEMRIG	LRRC7	626	Q96NW7
DFEETVPTSGRMHID	KCNH7	966	Q9NS40
EEMSGEVRFSSHLPQ	CHUK	246	O15111
TITFPISHSMLDEDG	PHKA1	561	P46020
GAMTVETHEALSFLP	LRRC53	1186	A6NM62
ITMSGDDHPRAFVLD	LRP1	2326	Q07954
HGEAMAEPVASEFVS	KIF26B	1306	Q2KJY2
HEMIPLDSFVGQSAD	HERC1	4646	Q15751
DLFDIMSGQTDVDHP	BECN1	121	Q14457
VLPLAFLGMHEIADE	ECPAS	1481	Q5VYK3
IPESHEIVDLGTMVT	PCLO	2036	Q9Y6V0
SVTMFILLGFTDHPE	OR5A1	11	Q8NGJ0
HGEEVSPAASDLAMV	MTSS2	436	Q765P7
ALEMTGIHAPESSQE	PDZD2	1361	O15018
VASDLHGEDMIVTPF	PDE4C	141	Q08493
HGEDMIVTPFAQVLA	PDE4C	146	Q08493
FGHLEVPSSMFRLDE	LPO	466	P22079
EVHTMEGDPDTLAEF	FAM153A	131	Q9UHL3
LEVIPLVQTFGHMEF	HEXD	81	Q8WVB3
EGLREIHSDIFSPMD	LRP6	256	O75581
VHFPDALEMLSLEGA	LRRK2	571	Q5S007
DGEVTKIMSPHFEEI	METTL9	156	Q9H1A3
AIFLIVFHMDPSDDL	LRRC52	196	Q8N7C0
ADITISLDGVPFLMH	GDPD5	261	Q8WTR4
SMHFLPQVDEIVVLG	ABCC2	821	Q92887
LHSETQRGDVFVPME	LAMA5	1716	O15230
GISDHPQLEMIFFIA	OR2C1	16	O95371
HVAEMEDPSTGAARV	HK3	351	P52790
IPKIVAFETVHSMDG	ALAS2	321	P22557
IVFGTDMKEVDPISH	MAGEA13P	156	A6NCF6
FVRMIAPEGSLVFHE	PITPNB	71	P48739
VEPGEHVTGMELEFK	PTPRS	1671	Q13332
SLDQSVTHLMGLFEP	ALPI	276	P09923
DSPGLVTIAHSMEAV	ORC1	741	Q13415
LEIEGEDFPFVFHSM	OSGIN2	271	Q9Y236
VRVDDEMPQHAVLSG	CADM1	281	Q9BY67
MGVITFLFLIEHPED	SLC37A2	221	Q8TED4
SIAPEDPFVMHEVGV	CDC16	396	Q13042
EDGFSARELMIHAPT	CEP104	16	O60308
PEELQELVDTAHSMG	GBE1	266	Q04446
EFTSDGIPVLMHDNT	GDE1	101	Q9NZC3
PEERMLAAATAFTHI	HYLS1	16	Q96M11
AVEFHPDTGDIIMEF	PRMT7	671	Q9NVM4
PDTGDIIMEFRHADT	PRMT7	676	Q9NVM4
ELSPTPTEELVHMFN	DMAP1	351	Q9NPF5
LPVDHILAGSFETAM	COPA	926	P53621
LSLIECGPVHTAFME	HSD17B1	181	P14061
GFDLVVSPLVHAMSE	EXTL3	311	O43909
EHLAAIVDAVGTMLP	CHAC1	196	Q9BUX1
HFSEPEITLIIFGVM	GYPA	86	P02724
MELPAVGEHVFAVES	CBX4	1	O00257
HEAVGEIMSLSAATP	ACE2	401	Q9BYF1
DAHVEAVMILGEPFA	COQ8B	436	Q96D53
SDPAAIIHDFEKGMT	ITM2A	136	O43736
QVEHPVTEMITGTDL	MCCC1	341	Q96RQ3
HIRATFDPDTGLLME	MAN2B1	611	O00754
TPLMEAAAAGHEIIV	ANKS3	171	Q6ZW76
VMDLGLSEDHFSRPV	DEF8	121	Q6ZN54
QPTVEAGVAHMIEAL	DENND4B	971	O75064
HLGMESFIVVTECEP	CAMKK2	46	Q96RR4
MEQPLDLTHIVGTEV	DYNC1H1	4021	Q14204
DAMFPVTHIAGETVI	PRKAR1B	151	P31321
MVDHLLPVDENFSSP	KLF15	1	Q9UIH9
EQHFPEVMLGEEFLS	KLHL3	176	Q9UH77
ALSHDSIFMLGPEPE	KIAA1210	226	Q9ULL0
ARVHVSEEGTEPEAM	GSN	256	P06396
MPIAHEFSPDVVLVS	HDAC5	946	Q9UQL6
EVDGLPFHNTHAEMI	DGLUCY	591	Q7Z3D6
TMDFPILHLDGIVED	GRIK5	246	Q16478
MEQALHLDFGTELEP	DIPK1A	116	Q5T7M9
MPTTVDDVLEHGGEF	SLC22A2	1	O15244
EIPHEMGDFAVLLSS	SLC39A12	581	Q504Y0
APLFAGTEHRAIMVD	RYR1	2566	P21817
IGVLSSHPFESDTEM	PPFIA2	606	O75334
GLELPVVMETDHIAS	PRDM4	261	Q9UKN5
MALVGSFVPAEEAEI	MSH5	611	O43196
ADLVAITELMHPVGA	GSTT1	166	P30711
MRPVLAAHVFSGEEE	SLC29A3	261	Q9BZD2
GPVQALMEVHEDFFL	TINAGL1	361	Q9GZM7
IHLIVMDPFVDLGIT	SCN4A	571	P35499
GASILPEHDMELAFD	TDRD9	1261	Q8NDG6
SSIPEMILGHLFSQE	NDRG2	191	Q9UN36
EVFHNLDPDGTMSVE	NIN	226	Q8N4C6
VVDIMHGLEPQTIES	EIF5B	726	O60841
DPVGDIVSFMHSFEE	FAF2	131	Q96CS3
MSLVHVGTEAFPISD	ERCC5	476	P28715
VLALEHMFAPVLDGA	PTCH1	1116	Q13635
HMFAPVLDGAVSTLL	PTCH1	1121	Q13635
FREMIPFAVVGSDHE	SEPTIN9	491	Q9UHD8
EEPQEGLEFAHMALA	SH3TC1	1166	Q8TE82
LLGSEEPTEMHLDFI	SECISBP2L	596	Q93073
GPVHAPVFTMSVDVD	STRBP	411	Q96SI9
TLLTHMGVNPLEAEE	NSMCE4A	166	Q9NXX6
FKMVSEPVAHGVAEE	NAP1L3	6	Q99457
IVESFEEAPLHVMVF	SPTLC3	51	Q9NUV7
GTMAEETAPAVLERH	RGN	116	Q15493
LMSFSPAEIPVHEVE	ITGAL	621	P20701
PMSVGTLEEIIDDNH	PSMC1	106	P62191
VHAVIGVLMDDTDPL	PSMC1	156	P62191
HEDLPSGSFIQDDMV	SVEP1	261	Q4LDE5
FSMHDLTTIQGDEPV	REEP3	151	Q6NUK4
PGESMSTDLVHFDIP	ARHGAP44	766	Q17R89
GFLEEVMHDPELLTQ	RASGRF1	981	Q13972
ASVNEVDFEGRTPMH	RIPK4	576	P57078
GAIVSLSDEAPHMLV	OSBPL10	126	Q9BXB5
FVVFTETDLHMPGAP	SLC6A18	386	Q96N87
VLAHTEMPTTLEGAE	SPTBN1	1191	Q01082
EFIDRQPTMVHDGSL	ABCB9	481	Q9NP78
PLMEAASAGHVEVAR	ANKHD1	341	Q8IWZ3
FSFHVPSLEELAGVM	C11orf54	6	Q9H0W9
LTFIRAAETDPGMVH	CNOT2	361	Q9NZN8
IDTESPLMEMFVAHG	SLC7A14	316	Q8TBB6
FIVLTTSAGIMDHEE	RPS15A	101	P62244
PADLQSHLGTEVMVE	TULP4	1296	Q9NRJ4
TLEVRFTPHAEMDLG	TRMO	336	Q9BU70
ILGDVNSIMDPEIHA	RALGAPA1	1071	Q6GYQ0
PMKDETHFEVVESGR	VWF	946	P04275
GLHMATAVLEESDQP	RNASE10	26	Q5GAN6
ELASFLMDHVFIQPG	STAG3	836	Q9UJ98
HPDEEMGFTIDIKSF	PSPC1	56	Q8WXF1
MEEEGHSDLISFQPT	TMEM94	921	Q12767
ETSPHVIQAVMGALE	SF3B1	1221	O75533
VDVLMEAAAHGESDP	POLR2A	1436	P24928
GISHSIMFEELPNVD	PIEZO2	2691	Q9H5I5
FTLDCTHPVEDGIMD	RPL22	21	P35268
PTLFTEMDTLQHDGD	SLC4A5	111	Q9BY07
MNAHLPFAVVGSTEE	SEPTIN8	231	Q92599
FVDNMTLSGPDLELH	STAB1	2376	Q9NY15
LIVSEGKMAPFTHDF	WIF1	56	Q9Y5W5
LVASSPEMGQDFDHV	SPTB	1711	P11277
EAVELHFSSMQGIPL	TTC21A	431	Q8NDW8
RMAEIGEHVAPSEAA	CAD	521	P27708
VAGSTVMVIHAPEEE	NIPAL4	166	Q0D2K0
FSHEVGSELASVPVM	ZC3H7A	226	Q8IWR0
QEASEETELHRMPVG	ZNF621	101	Q6ZSS3
PELHDFMQSAEVGTI	TBC1D20	201	Q96BZ9
IQTEMETVPEAGTHE	ZNF222	51	Q9UK12
LSEELAGHQMPITDI	WDR54	156	Q9H977